Overview
C11 Sodium Acetate PET/CT Imaging of PCa
Status:
No longer available
No longer available
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
The investigators propose to conduct Carbon-11 Sodium Acetate PET/CT studies. The purpose of our study is to evaluate the impact of Carbon-11 Sodium Acetate PET/CT studies on patient management in patients with prostate cancer.Details
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Criteria
Inclusion Criteria:- Diagnosed prostate cancer
- Able to remain still for duration of each imaging procedure (about 30 minutes)
Exclusion Criteria:
- Inability to complete the needed investigational and standard-of-care imaging
examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)
- Any additional medical condition, serious concurrent illness, or other extenuating
circumstance that, in the opinion of the Investigator, may significantly interfere
with study compliance.